Bullish China

01. Accel Partners
02. Softbank
03. Index Ventures
04. Sequoia Capital
05. Kleiner Perkins Caufield & Byers
06. DCM
07. Insight Venture Partners
08. Draper Fisher Jurveston
09. Sofinnova Partners
10. Matrix Partners
11. New Enterprise Associates
12. Bessemer Venture Capital
13. Greylock Partners
14. Wellington Partners
15. Khosla Ventures
16. Norwest Venture Partners
17. Benchmark Capital
18. TVM Capital
19. Battery Ventures
20. Lightspeed Venture Capital
21. August Capital
22. Pitango Venture Capital
23. GRP Partners
24. IDGVC Venture Partners
25. Alta Partners

26. Trident Capital
27. Institutional Venture Partners
28. Allegis Capital
29. Legend Capital
30. Reliance Technology Ventures
31. InterWest Partners
32. Mangrove Partners
33. Banexi Ventures
34. Technology Crossover Partners
35. Foundation Capital
36. Charles River Ventures
37. Mayfield Venture Capital
38. JAFCO Ventures
39. Redpoint Ventures
40. Menlo Ventures
41. Azure Capital Partners
42. Oak Investment Partners
43. US Venture Partners
44. Balderton Capital Management
45. Mohr Davidow Ventures
46. Carmel Ventures
47. Amadeus Capital Partners
48. Globespan Capital Partners
49. BDC Venture
50. Venrock Associates

51. Canaan Partners
52. CDH Ventures
53. FTQ
54. Polaris Venture Partners
55. General Catalyst Partners
56. Sierra Ventures
57. CDC Innovation
58. Atlas Ventures
59. Globis Capital
60. Highland Capital Partners
61. Crescendo Ventures
62. Ignition Partners
63. Nexus India Capital
64. Trinity ventures
65. Hummer Winblad Venture Partners
66. Sigma Partners
67. Allen Buckridge Ventures
68. Walden International
69. Northern Light Venture Capital
70. Doughty Hanson Technology Ventures
71. Morgenthaler Ventures
72. CMEA Ventures
73. KTB Venture
74. Tallwood Venture Capital
75. ATA Ventures

76. Shenzen Capital Group
77. Vengrowth Capital Fund
78. Early Bird
79. Jerusalem Venture Partners
80. Advent Ventures
81. Northzone Capital
82. Southern Cross Venture Partners
83. Emergence Capital Partners
84. Artiman Ventures
85. GSR Venture
86. Bluerun Ventures
87. GGV Capital
88. Garnett and Helfrich Capital
89. Granite Ventures
90. Vantage Point Venture Partners
91. Shasta Ventures
92. iGlobe Partners
93. DN Capital
94. Northcap Partners
95. Partech Ventures
96. Scale Venture Partners
97. Mustang Ventures
98. Gemini Israel Fund
99. Gabriel Venture Partners
100. Zone Venture Capital

Whom You Know Matters: Venture Capital Networks and Investment Performance –

It is normal for VC and PE to lose money, they can say that is must-pay tutor fee. Here are few main reasons why venture capital fail in China.

First, the lack of an ideal entrepreneurial team. In mature market, such as in Silicon Valley, both investors and inventors believe the most important business sccess is an ideal: if an inventor would like to do a samll business, to do your things dillently enough; for a traget of becoming medium business, be smarter, even a bit than other, howerver, as to enterprises of big businesses, there must be a moral and ideals. Usually, Chinese ignore or have not realizen the last factor.

Second, enterrpises cannot insist on its own direction of development, or get lost on the road of their long run target. It alwasy hard to adhere to the original and eventually die.

Third, enterprises are unable to adjust the market development strategies according to the firece market competition.

Forth, IPO is not the final aim. Some VC and PE just closely watch some project of pre-IPO and forget their untimate target. Certainly, it is irreproachability.

Fifth, key persons in company should better be shareholders or compensated with corressponding agreements. A stable staff team is the base of success.

Sixth, the risk of big boss spread too many industries. Some China enterprises think they can spread risk and like to persue the hottest industries like GE (Jack Welch and the GE Way is the business Bible in China)

7, The expansion is a dream, as well as a way to slove many problems. Undoubtedly, the tight cash status will bring out big risk, especially at the current situation of financial crisis.

8. Chinese team management often is a group of technical designers or programmers, the same as USA innovation enterprises, however, westeron culture are more likely to accept other experts in marketing, financing position comparing to Chinese culture.

VC watching

After five years of annual increases in the amount of venture capital funding flowing to health care companies, 2008 marked a sharp departure from that trend.
For the year ended December 31, 2008, the health care venture capital market experienced a 28% drop in funding and an 18% drop in deal volume, compared with the year-end totals for 2007. In 2008, health care companies publicly announced 396 venture capital investments totaling $7.0 billion.
Medical devices led the health care sectors during 2008, raising 32% of the funding and announcing 30% of the deals, including the largest deal of the year,a $250 million investment by GTCR in Devicor Medical Products, which was started up specifically to acquire medical device companies. The bio sectors followed, with biotechnology companies capturing 22% of both deals and dollars, and biopharmaceutical companies securing 19% of the capital in 17% of the deals. The second largest-deal of the year, a $100 million Series E led by Deerfield Management, was announced by a biotech, Pacific Biosciences, while the third-largest, a $93 million Series B led by Nomura Phase4 Ventures, was announced by a biopharma, OncoMed Pharmaceuticals.
“Venture capital investors continue to focus on identifying quality investments in the health care sectors, including companies that are intent on improving the efficiency, effectiveness or safety of health care processes or products,” commented Gretchen S. Swanson, Editor of Healthcare Corporate Finance News.
“Conserving cash and staying lean may be paramount for entrepreneurs right now, but venture capitalists are generally expected to continue investing equity in both new and existing portfolio companies.”

Stephen M. Monroe, Partner and Managing Editor of Irving Levin Associates, Inc., stated, “The recession in the overall economy is reflected somewhat in a slowdown in the health care venture capital market, but the health care markets, including M&A, have not been hit as hard as some other industry sectors.
Private, equity-backed companies with solid management and sound strategies are faring better right now than most companies that rely on credit or the public markets for operating capital.”

Healthcare Corporate Finance News reports weekly on financial events in the fast-paced venture capital, private and public equity, and merger and acquisition markets for health care companies, and provides subscribers with access to a searchable online database of health care venture capital deals.
This monthly newsletter and weekly email update is published by Irving Levin Associates, Inc., a leading financial publisher and source of market intelligence since 1948. For more information, please call 1-800-248-1668.

*To receive this press release via email, send a message to pressreleases@levinassociates.com.
Healthcare Corporate Finance News
Stephen M. Monroe, Partner
Gretchen S. Swanson, Editor
Phone: 800-248-1668
Fax: 203-846-8300
Copyright Business Wire 2009